1403501-14-3

Upstream product

• 1403501-00-7 ethyl 5-cyano-2-(4-methoxyphenyl)-4-(2-nitrophenyl)-6-thioxo-1,6-dihydropyridine-3-carboxylate 
• 2881-83-6 ethyl 4-methoxybenzoylacetate 
• 1403501-10-9 ethyl 5-cyano-2-(4-methoxyphenyl)-6-(methylthio)-4-(2-nitrophenyl)nicotinate 
• 93440-30-3 2-cyano-3-(2-nitrophenyl)prop-2-enethioamide 
• 1403501-12-1 6-hydroxy-4-(4-methoxyphenyl)-2-(methylthio)-5-oxo-5,6-dihydrobenzo[c][2,7]naphthyridine-1-carbonitrile 

Downstream Products

• 1403500-47-9 1-amino-5-(4-hydroxyphenyl)-3H-benzo[f]pyrazolo[3,4-c][2,7]naphthyridin-6(7H)-one 

Relevant academic research and scientific papers

TRI - AND TETRACYCLIC PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS AS ANTINEOPLASTIC AGENT

The present invention relates to compounds of following general formula (I): and to the pharmaceutically acceptable salts of same, the tautomers of same, the stereoisomers or mixture of stereoisomers in any proportions of same, such as a mixture of enantiomers, notably a racemic mixture, as well as to methods for preparing same and uses of same, notably as an antineoplastic agent.

TRI- AND TETRACYCLIC PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS AS ANTINEOPLASTIC AGENT

The present invention relates to compounds of following general formula (I): and to the pharmaceutically acceptable salts of same, the tautomers of same, the stereoisomers or mixture of stereoisomers in any proportions of same, such as a mixture of enantiomers, notably a racemic mixture, as well as to methods for preparing same and uses of same, notably as an antineoplastic agent